title: Anti-EGFR monoclonal antibodies in the treatment of non-small cell lung cancer.
authors.affiliation: Divisione di Oncologia Medica Falck, Ospedale Niguarda Ca' Granda, Milano, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Sartore-Bianchi
authors.forename: G
authors.initials: G
authors.lastname: Cerea
authors.forename: I
authors.initials: I
authors.lastname: Schiavetto
authors.forename: L
authors.initials: L
authors.lastname: Giannetta
authors.forename: R
authors.initials: R
authors.lastname: Ricotta
authors.forename: M R
authors.initials: MR
authors.lastname: Maugeri
authors.forename: M
authors.initials: M
authors.lastname: Moroni
authors.forename: G
authors.initials: G
authors.lastname: Marrapese
authors.forename: S
authors.initials: S
authors.lastname: Siena
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008495:Medical Oncology; D011379:Prognosis; D047428:Protein Kinase Inhibitors / Q000008:administration & dosage
chemical_list: D000911:Antibodies, Monoclonal; D047428:Protein Kinase Inhibitors; D066246:ErbB Receptors